We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Ranolazine USP Related Compound C
N-Nitroso Ranolazine USP Related Compound C
CAT No SRC-N014061
CAS No NA
Mol.F. C14H20N4O2
Mol.Wt. 276.34
INV STATUS IN STOCK
Indapamide EP Impurity A
Indapamide EP Impurity A
CAT No SRC-N014062
CAS No 85440-79-5
Mol.F. C9H10N2O
Mol.Wt. 162.2
INV STATUS IN STOCK
N-Nitroso Rasagiline
N-Nitroso Rasagiline
CAT No SRC-N014063
CAS No 2470278-90-9
Mol.F. C12H12N2O
Mol.Wt. 200.2
INV STATUS IN STOCK
N-Nitroso-Cinacalcet
N-Nitroso-Cinacalcet
CAT No SRC-N014064
CAS No NA
Mol.F. C22H21F3N2O
Mol.Wt. 386.4 g/mol
INV STATUS IN STOCK
N-Nitroso Galtifloxacin Impurity 2
N-Nitroso Galtifloxacin Impurity 2
CAT No SRC-N014065
CAS No NA
Mol.F. C19H21FN4O5
Mol.Wt. 404.40
INV STATUS IN STOCK
Nitrosopyrrolidine
Nitrosopyrrolidine
CAT No SRC-N014066
CAS No 930-55-2
Mol.F. C4H8N2O
Mol.Wt. 100.1
INV STATUS IN STOCK
N-Nitroso Methylethanolamine (NNMEA)
N-Nitroso Methylethanolamine (NNMEA)
CAT No SRC-N014067
CAS No 26921-68-6
Mol.F. C3H8N2O2
Mol.Wt. 104.1
INV STATUS IN STOCK
Buspirone Nitroso Impurity 1
Buspirone Nitroso Impurity 1
CAT No SRC-N014068
CAS No 872826-80-7
Mol.F. C8H11N5O
Mol.Wt. 193.2g/mol
INV STATUS IN STOCK
Trolamine Nitroso Impurity 1
Trolamine Nitroso Impurity 1
CAT No SRC-N014069
CAS No 1116-54-7
Mol.F. C4H11N3O2
Mol.Wt. 133.2
INV STATUS UNDER SYNTHESIS
4-nitrosomethylaminopyridine
4-nitrosomethylaminopyridine
CAT No SRC-N014070
CAS No 16219-99-1
Mol.F. C6H7N3O
Mol.Wt. 137.1g/mol
INV STATUS IN STOCK

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.